Substituted tetrahydronaphthaline and analogous compounds

US6586613B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Arndt Brandes · Wuppertal, DE
• Michael Logers · Wuppertal, DE
• Jurgen Stoltefuss · Haan, DE
• Gunter Schmidt · Houghton, US
• Klaus-Dieter Bremm · Recklinghausen, DE
• Hilmar Bischoff · Wuppertal, DE
• Delf Schmidt · Wuppertal, DE
• Stefan Antons · Leverkusen, DE
• Holger Paulsen · Wuppertal, DE
• Stephan-Nicholas Müller · Wuppertal, DE
• Paul Naab · Bad Reichenhall, DE
• Carsten Schmeck · Wuppertal, DE

Key dates

• Filing date: Mar 17, 2000
• Grant date: Jul 1, 2003
• Expiry date: Mar 17, 2020

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F7/1804
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Substituted tetrahydro-naphthalenes and analogous compounds are prepared by reducing or condensing appropriate functional substituents in substituted tetrahydro-naphthalenes and analogous compounds by customary methods and converting functional groups in this manner into the desired groups. The compounds according to the invention are suitable for use as active compounds in pharmaceuticals, in particular in pharmaceuticals for treating arteriosclerosis and also dyslipidaemias.